Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate
The past decade has seen a proliferation of drugs that target epigenetic pathways. Many of these drugs were developed to treat acute myeloid leukemia, a condition in which dysregulation of the epigenetic landscape is well established. While these drugs have shown promise, critical issues persist. S...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2020-10-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/10064 |